CLS CEO Mike Guerra’s Statement on Senate Action on SBIR and STTR

Statement from Mike Guerra, President & CEO, California Life Sciences and Chair of the Council of State Bioscience Associations

“The SBIR/STTR program is a powerful tool to grow and foster innovation in the states. It ensures that emerging companies have access to the capital they need to tackle some of the most pressing medical and scientific challenges facing society today. The program helps strengthen local biotech hubs and ensures that our country is globally competitive in this critical sector of our economy. CSBA applauds Senate Leadership for prioritizing bipartisan passage of this important legislation. We look forward to swift passage in the House and will work closely with Congress to ensure this important program continues to reach companies working on the next generation of medical breakthroughs.“

About California Life Sciences
California Life Sciences is the voice for more than 1,300 biotech, pharmaceutical, and medical technology companies, research institutions, and leading universities. The organization advances public policy that promotes innovation and improves access to transformative technologies while supporting California’s position as the global leader in life sciences. For more information, visit www.califesciences.org.

###

For media inquiries, please contact: Andrea Riccio [email protected]